SCHEMBL25210264

SCHEMBL25210264

Brc1ccc(-c2c3ccccc3c(-c3ccccc3)c3ccccc23)cn1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.46
MAPK1 P28482 2/20 0.46
KDM4E B2RXH2 2/20 0.46
MAPT P10636 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
NFKB1 P19838 2/20 0.44
NFKB2 Q00653 2/20 0.44
RELA Q04206 2/20 0.44
ACHE P22303 2/20 0.38
ALDH1A1 P00352 1/20 0.38
ESR1 P03372 3/20 0.38
ESR2 Q92731 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C19 P33261 2/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29776270 0.98 NPC1 (0.47) L3MBTL1MAPK1KDM4EMAPTTDP1
SCHEMBL20176443 0.98 NPC1 (0.47) L3MBTL1MAPK1KDM4EMAPTTDP1
SCHEMBL25204935 0.90 NPC1 (0.41) L3MBTL1MAPK1KDM4EMAPTTDP1
SCHEMBL25226979 0.90 NPC1 (0.41) L3MBTL1MAPK1KDM4EMAPTTDP1
SCHEMBL29776272 0.88 L3MBTL1 (0.42) L3MBTL1MAPK1KDM4EMAPTTDP1
SCHEMBL20176553 0.88 L3MBTL1 (0.42) L3MBTL1MAPK1KDM4EMAPTTDP1
SCHEMBL29776275 0.87 CYP19A1 (0.47) L3MBTL1MAPK1KDM4EMAPTTDP1
SCHEMBL20176547 0.87 CYP19A1 (0.47) L3MBTL1MAPK1KDM4EMAPTTDP1
SCHEMBL25204761 0.83 PIK3CA (0.46) MAPTNPC1RAB9ASMN1; SMN2NFKB1
SCHEMBL25228669 0.83 PIK3CA (0.46) MAPTNPC1RAB9ASMN1; SMN2NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
CN-110023305-B Organic light-emitting compound and organic electroluminescent element using same 索路思高新材料有限公司 2022-08-09 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same OR10J3, ICMT, SLCO4C1 L3MBTL1 869/4885MAPK1 3159/4885KDM4E 2080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.